These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2970754)

  • 1. [Clinical use of pantethine by parenteral route in the treatment of hyperlipidemia].
    Arsenio L; Bodria P; Bossi S; Lateana M; Strata A
    Acta Biomed Ateneo Parmense; 1987; 58(5-6):143-52. PubMed ID: 2970754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pantethine improves the lipid abnormalities of chronic hemodialysis patients: results of a multicenter clinical trial.
    Donati C; Barbi G; Cairo G; Prati GF; Degli Esposti E
    Clin Nephrol; 1986 Feb; 25(2):70-4. PubMed ID: 3516477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of long-term treatment with pantethine in patients with dyslipidemia.
    Arsenio L; Bodria P; Magnati G; Strata A; Trovato R
    Clin Ther; 1986; 8(5):537-45. PubMed ID: 3094958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of coenzyme A vs pantethine for the treatment of patients with hyperlipidemia: A randomized, double-blind, multicenter study.
    Chen YQ; Zhao SP; Zhao YH
    J Clin Lipidol; 2015; 9(5):692-7. PubMed ID: 26350816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children.
    Bertolini S; Donati C; Elicio N; Daga A; Cuzzolaro S; Marcenaro A; Saturnino M; Balestreri R
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):630-7. PubMed ID: 3098691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A double-blind clinical trial--the effects of pantethine on serum lipids in patients with hyperlipidemia].
    Lu ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug; 17(4):221-3. PubMed ID: 2697544
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the cholesterol-lowering effectiveness of pantethine in women in perimenopausal age].
    Binaghi P; Cellina G; Lo Cicero G; Bruschi F; Porcaro E; Penotti M
    Minerva Med; 1990 Jun; 81(6):475-9. PubMed ID: 2359503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lowering effect of pantethine on plasma beta-thromboglobulin and lipids in diabetes mellitus.
    Eto M; Watanabe K; Chonan N; Ishii K
    Artery; 1987; 15(1):1-12. PubMed ID: 2963604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of pantethine in dyslipidemia of chronic uremic patients under dialysis treatment].
    Bergesio F; Ciuti R; Innocenti D; Galli GA; Frizzi V
    G Clin Med; 1985; 66(11-12):433-40. PubMed ID: 3835087
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperlipidemia, diabetes and atherosclerosis: efficacy of treatment with pantethine].
    Arsenio L; Caronna S; Lateana M; Magnati G; Strata A; Zammarchi G
    Acta Biomed Ateneo Parmense; 1984; 55(1):25-42. PubMed ID: 6232801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment.
    Gensini GF; Prisco D; Rogasi PG; Matucci M; Neri Serneri GG
    Int J Clin Pharmacol Res; 1985; 5(5):309-18. PubMed ID: 4066081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pantethine on lipoprotein profiles and HDL subfractions in experimentally hypercholesterolemic rabbits.
    Tomikawa M; Nakayasu T; Tawara K; Kameda KY; Abiko Y
    Atherosclerosis; 1982 Feb; 41(2-3):267-77. PubMed ID: 7066075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the efficacy of pantethine, acipimox, and bezafibrate on plasma lipids and index of cardiovascular risk in diabetics with dyslipidemia].
    Tonutti L; Taboga C; Noacco C
    Minerva Med; 1991 Oct; 82(10):657-63. PubMed ID: 1745376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction.
    Murai A; Miyahara T; Tanaka T; Sako Y; Nishimura N; Kameyama M
    Artery; 1985; 12(4):234-43. PubMed ID: 3935096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pantethine on different models of experimental hyperlipidemia in rodents: a comparison with clofibrate.
    Farina R; Lovati MR; Raucci G; Sirtori CR
    Pharmacol Res Commun; 1982 Jun; 14(6):499-510. PubMed ID: 7122675
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of pantethine on the lipoprotein abnormalities in survivors of cerebral infarction (author's transl)].
    Murai A; Miyahara T; Tanaka T; Sako Y; Kameyama M; Nishimura N
    Nihon Ronen Igakkai Zasshi; 1980 Nov; 17(6):624-9. PubMed ID: 7206301
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic efficacy of pantothenic acid preparations in ischemic heart disease patients].
    Borets VM; Lis MA; Pyrochkin VM; Kishkovich VP; Butkevich ND
    Vopr Pitan; 1987; (2):15-7. PubMed ID: 3590676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pantethine, diabetes mellitus and atherosclerosis. Clinical study of 1045 patients].
    Donati C; Bertieri RS; Barbi G
    Clin Ter; 1989 Mar; 128(6):411-22. PubMed ID: 2524328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia.
    Gaddi A; Descovich GC; Noseda G; Fragiacomo C; Colombo L; Craveri A; Montanari G; Sirtori CR
    Atherosclerosis; 1984 Jan; 50(1):73-83. PubMed ID: 6365107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pantethine, a derivative of vitamin B(5) used as a nutritional supplement, favorably alters low-density lipoprotein cholesterol metabolism in low- to moderate-cardiovascular risk North American subjects: a triple-blinded placebo and diet-controlled investigation.
    Rumberger JA; Napolitano J; Azumano I; Kamiya T; Evans M
    Nutr Res; 2011 Aug; 31(8):608-15. PubMed ID: 21925346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.